Karyopharm Therapeutics, Inc. KPTI
NASDAQ · United States · Health Technology
$0.8109-0.06 (-6.45%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -2.32 | -1.37 | -69.1% | $33.43M | +3.8% | -0.5%$2.03→$2.02 |
| Q1 2026 | 2026-05-14 | -1.24 | -1.44 | +13.9% | — | — | -13.3%$8.85→$7.67 |
| Q4 2025 | 2026-02-12 | -2.23 | -2.00 | -11.5% | — | — | +16.4%$7.37→$8.58 |
| Q3 2025 | 2025-11-03 | -3.82 | -3.25 | -17.5% | — | — | -2.6%$5.80→$5.65 |
| Q2 2025 | 2025-08-11 | -4.07 | -3.91 | -4.1% | — | — | — |
| Q1 2025 | 2025-05-12 | -2.77 | -3.09 | +10.4% | — | — | — |
| Q4 2024 | 2025-02-19 | -3.60 | -4.03 | +10.7% | — | — | — |
| Q3 2024 | 2024-11-05 | -3.90 | -3.92 | +0.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.